Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-17T14:50:19.293Z Has data issue: false hasContentIssue false

DOPA-sensitive dystonia-plus syndrome

Published online by Cambridge University Press:  18 February 2005

Wilfrid Casseron
Affiliation:
Service de Neurologie et Maladies Neuromusculaires, CHU Timone, France.
Pierre Genton
Affiliation:
Hôpital Henri Gastaut, Centre St Paul, Marseille, France.
Get access

Abstract

We report on two sisters with a childhood-onset form of predominantly axial dystonia with marked diurnal fluctuations. Onset of clinical features was at approximately 6 years of age. Associated features included marked fatigue, slight facial dysmorphism, short stature, obesity, and learning disability. Dystonia and fatigue responded to 3,4-dihydroxyphenylalanine (DOPA) therapy, with recurrence of symptoms upon withdrawal; the efficacy has been maintained over 7 years. Other symptoms were not influenced. There was no other case in the family (which included an older, healthy brother), except for non-specific fatigue without dystonia in the mother, and there was no significant family history except for obesity on the father's side. These observations are discussed in relation to the classical descriptions of Segawa syndrome, and to more recent reports of childhood onset, age-related, and transient benign paroxysmal tonic upgaze and ataxia. The combination of symptoms, their sensitivity to DOPA, and their persistence throughout childhood constitute, to our knowledge, a new clinical entity, which we propose to categorize as a DOPA-sensitive dystonia-plus syndrome.

Type
Case Report
Copyright
© 2005 Mac Keith Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)